BioWorld

Dec. 8, 2008

Deerfield Counters Proposed NitroMed-Archemix Merger

NitroMed Inc. shareholder Deerfield Management is less than thrilled with the company's plan to serve as a public shell for a reverse merger with privately held Archemix Corp. (BioWorld Today) Read More

Stupak Urges Obama to Go Outside the FDA for New Chief

Study Shows How Gene Variation Affects Anemia

ISTA's Phase III Eye Drug Study Region Showed Skewed Results

Departing Execs, Halted Trials Send Orexigen Shares Falling

Other News To Note

Clinic Roundup

Appointments And Advancements

Financings Roundup

Today's news in brief

BioWorld

BioWorld briefs for Dec. 24, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 24, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

BioWorld

Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...

Big pharma taps fast Asia innovation in search of next Keytruda

BioWorld

Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...